melatonin has been researched along with Ebola Hemorrhagic Fever in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin also has protective effects in cases of septic shock, which, although bacterial, has similar end-point presentations involving blood vessel leakage." | 2.52 | Ebola virus: melatonin as a readily available treatment option. ( Anderson, G; Maes, M; Markus, RP; Rodriguez, M, 2015) |
| "Melatonin has been shown to target these alterations." | 2.50 | Ebola virus disease: potential use of melatonin as a treatment. ( Korkmaz, A; Manchester, LC; Reiter, RJ; Tan, DX, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, DX | 1 |
| Korkmaz, A | 1 |
| Reiter, RJ | 1 |
| Manchester, LC | 1 |
| Anderson, G | 1 |
| Maes, M | 1 |
| Markus, RP | 1 |
| Rodriguez, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter Randomized Controlled Trial of the Efficacy of Melatonin in the Prophylaxis of SARS-coronavirus-2 Infection Among High Risk Contacts.[NCT04353128] | Phase 2/Phase 3 | 450 participants (Actual) | Interventional | 2020-04-20 | Completed | ||
| Prognostic Value of Serum Melatonin as a Biomarker for the Determination of Severe COVID-19 Infection in Pregnant Women[NCT05318144] | 228 participants (Actual) | Observational [Patient Registry] | 2021-06-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for melatonin and Ebola Hemorrhagic Fever
| Article | Year |
|---|---|
Ebola virus disease: potential use of melatonin as a treatment.
Topics: Animals; Antioxidants; Hemorrhagic Fever, Ebola; Humans; Melatonin | 2014 |
Ebola virus: melatonin as a readily available treatment option.
Topics: Africa, Western; Hemorrhagic Fever, Ebola; Humans; Immunologic Factors; Melatonin | 2015 |